Skip to content

GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry

By API User

IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce best-in-class biomedical research reagents. The specificity of these new antibodies is established through meticulous in-house validation testing based on knockdown/knockout methodologies complemented by other strategies. GeneTex has employed this process … Continued

CERA welcomes $10m kickstart for sight-saving eye clinical trials centre

By API User

A new world-leading eye clinical trials centre will give Victorians facing vision loss and blindness greater access to innovative, sight-saving treatments.Plans for the new centre, to be developed by the Centre for Eye Research Australia, have received a $10million kickstart from Breakthrough Victoria.CERA Managing Director Professor Keith Martin welcomed the investment in the future of … Continued

New 3D stretchable electronics can advance organ-on-chip technology

By API User

Engineers from UNSW Sydney have discovered a way to create flexible electronic systems on ultra-thin skin-like materials. The development allows entire stretchable 3D structures to operate like a semiconductor and could help significantly reduce the need for animal testing by making so-called organ-on-chip technology more effective. Down the track, the technology could also be used … Continued

Moolec Science Presents Third Quarter FY 2023 Business Update

By API User

LUXEMBOURG / ACCESSWIRE / May 30, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023. The main highlights of the Company’s business update are as follows: … Continued

Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts

By API User

WALTHAM, MA / ACCESSWIRE / May 24, 2023 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech’s … Continued